Artificial Intelligence (AI) ab dawaiyon ki duniya mein bhi apna magic dikhane wala hai. DeepMind ka spinoff, Isomorphic Labs, ne AI ki madad se kuch naye drugs design kiye hain. Aur ab yeh drugs human trials mein jaane wale hain.
Yeh update khud company ke president Max Jaderberg ne diya. Woh WIRED Health London event mein bole. Unhone kaha ki Isomorphic Labs ke paas ab “broad and exciting pipeline of new medicines” hai.
Kya Hai Isomorphic Labs Ka Plan?
Isomorphic Labs ka kaam hai AI ka use karke naye drugs design karna. Yeh company DeepMind ka hi ek hissa hai jo alag ho gaya hai. DeepMind ne pehle AlphaFold banaya tha jo protein structures predict karta hai. Ab Isomorphic Labs ussi technology ko drugs banane mein use kar rahi hai.
Max Jaderberg ne event mein bataya ki unki company ne AI models train kiye hain jo molecules ko samajhte hain aur unhe design karte hain. Yeh models itne accurate hain ki ab human trials ka time aa gaya hai.
Human Trials Kyon Important Hain?
Human trials ka matlab hai ki ab yeh drugs asli insaanon par test honge. Pehle yeh lab mein aur animals par test hue honge. Ab final stage se pehle ka important step hai. Agar human trials successful rahe, toh yeh drugs market mein aa sakte hain.
Isomorphic Labs ka kehna hai ki unke pipeline mein multiple drugs hain. Lekin abhi yeh clear nahi hai ki kaun si bimari ke liye yeh drugs hain. Company ne details share nahi ki.
Hamaari Baat: AI Ka Dawai Mein Future Bright Hai
Hamari nazar mein, yeh ek bada breakthrough hai. AI sirf chatbots aur images nahi bana sakta, balki life-saving drugs bhi design kar sakta hai. Isomorphic Labs ka human trials mein jaana ek signal hai ki AI healthcare mein real impact dene wala hai.
Lekin abhi patience rakhni padegi. Human trials mein time lagta hai — kai saal bhi lag sakte hain. Aur har drug successful nahi hota. Phir bhi, yeh shuruaat bohot positive hai. Agar yeh kaam karta hai, toh future mein AI drugs design ka standard tool ban sakta hai.
